MarketWatch

Immusoft Receives FDA Fast Track Designation for ISP-001, a First-in-Class Engineered B ...

SAN FRANCISCO, Oct. 21, 2025 /PRNewswire/ -- Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that the U.S. Food and Drug Administration ...
Morningstar

Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First ...

SAN DIEGO, July 29, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of ...
Monthly Prescribing Reference

Gamma Delta CAR T-Cell Therapy Fast Tracked for SLE With Extrarenal Involvement

ADI-001 is an allogeneic gamma delta CAR T-cell therapy that targets the B-cell antigen CD20. The Food and Drug Administration (FDA) has granted Fast Track designation to ADI-001 for the treatment of ...